Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes

Journal of Vascular Surgery

Volumn 53, Issue 3, 2011, Pages 651-657

  Robinson III, William P ^a   Nguyen, Louis L ^b   Bafford, Richard ^b   Belkin, Michael ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOVASCULAR SURGERY; FEMALE; FEMOROPOPLITEAL OCCLUSIVE DISEASE; GANGRENE; HUMAN; LEG; LEG ULCER; LIMB PAIN; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; SECOND TIME FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY STENTING; STENT; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BOSTON; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; RETREATMENT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 79951852276     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.09.020     Document Type: Article

References (19)

1. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009;50:54-60.
2. Matsi PJ, Manninen HI, Vanninen RL, Suhonen MT, Oksala I, Laakso M, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology 1994;191:727-33. (Pubitemid 24177892)
3. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-78. (Pubitemid 40342478)
4. Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL Sr, Goshima KR, et al. Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 2008;47:967-74.
5. Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg 2005;42:466-75.
6. Stanley B, Teague B, Raptis S, Taylor DJ, Berce M. Efficacy of balloon angioplasty of the superficial femoral artery and popliteal artery in the relief of leg ischemia. J Vasc Surg 1996;23:679-85. (Pubitemid 26131827)
7. DeRubertis BG, Faries PL, McKinsey JF, Chaer RA, Pierce M, Karwowski J, et al. Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 2007;246:415-22; discussion 22-4.
8. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38. (Pubitemid 27408567)
9. Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WE, Davies MG. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 2007;46:946-58; discussion 58.
10. Ryer EJ, Trocciola SM, DeRubertis B, Lam R, Hynecek RL, Karwowski J, et al. Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg 2006;20:440-6. (Pubitemid 44379320)
11. Treiman GS, Ichikawa L, Treiman RL, Cohen JL, Cossman DV, Wagner WH, et al. Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. J Vasc Surg 1994;20:577-85; discussion 85-7.
12. Baril DT, Marone LK, Kim J, Go MR, Chaer RA, Rhee RY. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions. J Vasc Surg 2008;48:627-33.
13. Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Percutaneous superficial femoral artery interventions for claudication - does runoff matter? Ann Vasc Surg 2008;22:790-8.
14. DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R, Ryer EJ, et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 2007;46:709-16. (Pubitemid 47454692)
15. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88. (Pubitemid 43872689)
16. Kalbaugh CA, Taylor SM, Blackhurst DW, Dellinger MB, Trent EA, Youkey JR. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg 2006;44:296-302; discussion 02:3.
17. Joels CS, York JW, Kalbaugh CA, Cull DL, Langan EM, 3rd, Taylor SM. Surgical implications of early failed endovascular intervention of the superficial femoral artery. J Vasc Surg 2008;47:562-5. (Pubitemid 351258281)
18. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
19. Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, et al. Infrainguinal vein bypass graft revision: factors affecting long-term outcome. J Vasc Surg 2004;40:916-23. (Pubitemid 39535221)